Skip to content

Drug interactions

Cladribine + Siponimod

Severity: Contraindicated

Cladribine and Siponimod: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cladribine causes prolonged lymphocyte depletion, and siponimod further reduces lymphocyte counts. Combined use may produce profound, long-lasting immunosuppression with serious infection risk.

What this interaction means in plain words

Cladribine and Siponimod are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Cladribine belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive lymphocyte depletion: cladribine is cytotoxic to lymphocytes and siponimod sequesters them in lymphoid tissue.

What to do

Do not use together; cladribine labeling advises against concomitant immunosuppressive or myelosuppressive therapy. When switching, check lymphocyte counts and allow adequate recovery before starting the second drug.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cladribine and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cladribine with Siponimod?

MediHelp rates the interaction as contraindicated. Cladribine and Siponimod are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Cladribine causes prolonged lymphocyte depletion, and siponimod further reduces lymphocyte counts. Combined use may produce profound, long-lasting immunosuppression with serious infection risk.

How serious is the interaction between Cladribine and Siponimod?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not use together; cladribine labeling advises against concomitant immunosuppressive or myelosuppressive therapy. When switching, check lymphocyte counts and allow adequate recovery before starting the second drug.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Fingolimod, Fluconazole, Influenza virus vaccine quadrivalent intranasal. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in